(+)-taxifolin multiple interactions EXP 6480464 taxifolin inhibits the reaction [Dibutyl Phthalate results in decreased expression of SOX9 mRNA] CTD PMID:32525071 (S)-nicotine decreases expression EXP 6480464 Nicotine results in decreased expression of SOX9 mRNA, Nicotine results in decreased expression of SOX9 protein CTD PMID:29660438 , PMID:31299270 1,1-dichloroethene increases expression ISO RGD:1322514 6480464 vinylidene chloride results in increased expression of SOX9 mRNA CTD PMID:26682919 1,2-dichloroethane increases expression ISO RGD:1322514 6480464 ethylene dichloride results in increased expression of SOX9 mRNA CTD PMID:28960355 1,2-dimethylhydrazine affects expression ISO RGD:1322514 6480464 1, 2-Dimethylhydrazine affects the expression of SOX9 mRNA CTD PMID:22206623 17alpha-ethynylestradiol multiple interactions ISO RGD:1322514 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of SOX9 mRNA CTD PMID:17942748 17alpha-ethynylestradiol increases expression EXP 6480464 Ethinyl Estradiol results in increased expression of SOX9 mRNA CTD PMID:30387366 17beta-estradiol multiple interactions ISO RGD:1322514 6480464 ESR1 protein promotes the reaction [Estradiol results in increased expression of SOX9 mRNA] CTD PMID:25210133 17beta-estradiol decreases expression ISO RGD:1322514 6480464 Estradiol results in decreased expression of SOX9 mRNA CTD PMID:19484750 17beta-estradiol increases expression ISO RGD:1322513 6480464 Estradiol results in increased expression of SOX9 mRNA CTD PMID:19619570 17beta-estradiol decreases expression ISO RGD:1322513 6480464 Estradiol results in decreased expression of SOX9 mRNA CTD PMID:19167446 , PMID:20106945 17beta-estradiol affects expression ISO RGD:1322513 6480464 Estradiol affects the expression of SOX9 mRNA CTD PMID:14699072 17beta-estradiol multiple interactions ISO RGD:1322513 6480464 [Arsenic co-treated with Estradiol] results in decreased expression of SOX9 mRNA more ... CTD PMID:17404688 more ... 17beta-estradiol increases expression ISO RGD:1322514 6480464 Estradiol results in increased expression of SOX9 mRNA CTD PMID:25210133 17beta-hydroxy-5alpha-androstan-3-one increases expression ISO RGD:1322513 6480464 Dihydrotestosterone results in increased expression of SOX9 mRNA CTD PMID:29581250 2,2',4,4'-Tetrabromodiphenyl ether affects expression ISO RGD:1322514 6480464 2 more ... CTD PMID:30561715 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1322514 6480464 Tetrachlorodibenzodioxin affects the expression of SOX9 mRNA CTD PMID:21570461 , PMID:24058054 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1322513 6480464 Tetrachlorodibenzodioxin affects the expression of SOX9 mRNA CTD PMID:31887333 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:1322513 6480464 Tetrachlorodibenzodioxin results in increased expression of SOX9 mRNA CTD PMID:15056799 , PMID:19619570 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:1322513 6480464 Tetrachlorodibenzodioxin results in decreased expression of SOX9 mRNA CTD PMID:20106945 , PMID:29704546 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:1322513 6480464 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [Tetrachlorodibenzodioxin results in decreased expression of SOX9 mRNA], [Estradiol co-treated with Tetrachlorodibenzodioxin] results in increased expression of SOX9 mRNA CTD PMID:19619570 , PMID:29704546 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:1322514 6480464 Tetrachlorodibenzodioxin results in decreased expression of SOX9 mRNA CTD PMID:15034205 , PMID:19770486 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:1322514 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of SOX9 mRNA more ... CTD PMID:17942748 more ... 2-hydroxypropanoic acid increases expression ISO RGD:1322513 6480464 Lactic Acid results in increased expression of SOX9 mRNA CTD PMID:30851411 3,3',5,5'-tetrabromobisphenol A decreases expression ISO RGD:1322514 6480464 tetrabromobisphenol A results in decreased expression of SOX9 mRNA CTD PMID:22677475 , PMID:35230478 3,4-methylenedioxymethamphetamine increases expression ISO RGD:1322514 6480464 N-Methyl-3, 4-methylenedioxyamphetamine results in increased expression of SOX9 mRNA CTD PMID:20188158 3-chloropropane-1,2-diol decreases expression EXP 6480464 alpha-Chlorohydrin results in decreased expression of SOX9 mRNA CTD PMID:28522335 3-Nitrobenzanthrone multiple interactions ISO RGD:1322513 6480464 EREG protein affects the reaction [3-nitrobenzanthrone results in increased expression of SOX9 protein] CTD PMID:34036453 3-Nitrobenzanthrone increases expression ISO RGD:1322513 6480464 3-nitrobenzanthrone results in increased expression of SOX9 mRNA, 3-nitrobenzanthrone results in increased expression of SOX9 protein CTD PMID:34036453 4,4'-diaminodiphenylmethane decreases expression ISO RGD:1322514 6480464 4, 4'-diaminodiphenylmethane results in decreased expression of SOX9 mRNA CTD PMID:18648102 4,4'-sulfonyldiphenol decreases methylation ISO RGD:1322514 6480464 bis(4-hydroxyphenyl)sulfone results in decreased methylation of SOX9 exon CTD PMID:33297965 4,4'-sulfonyldiphenol affects methylation ISO RGD:1322514 6480464 bis(4-hydroxyphenyl)sulfone affects the methylation of SOX9 gene CTD PMID:31683443 4-hydroxyphenyl retinamide increases expression ISO RGD:1322514 6480464 Fenretinide results in increased expression of SOX9 mRNA CTD PMID:28973697 5-aza-2'-deoxycytidine increases expression ISO RGD:1322513 6480464 Decitabine results in increased expression of SOX9 mRNA CTD PMID:19151715 5-azacytidine affects expression ISO RGD:1322514 6480464 Azacitidine affects the expression of SOX9 mRNA CTD PMID:18033690 acetamide increases expression EXP 6480464 acetamide results in increased expression of SOX9 mRNA CTD PMID:31881176 acrylamide decreases expression ISO RGD:1322513 6480464 Acrylamide results in decreased expression of SOX9 mRNA, Acrylamide results in decreased expression of SOX9 protein CTD PMID:32763439 afimoxifene multiple interactions ISO RGD:1322513 6480464 afimoxifene inhibits the reaction [Estrogens results in decreased expression of SOX9 mRNA] CTD PMID:21233418 afimoxifene decreases expression ISO RGD:1322513 6480464 afimoxifene results in decreased expression of SOX9 mRNA CTD PMID:16849584 aflatoxin B1 increases expression ISO RGD:1322513 6480464 Aflatoxin B1 results in increased expression of SOX9 mRNA CTD PMID:22100608 aflatoxin B1 increases expression EXP 6480464 Aflatoxin B1 results in increased expression of SOX9 mRNA CTD PMID:33354967 all-trans-retinoic acid decreases expression ISO RGD:1322514 6480464 Tretinoin results in decreased expression of SOX9 mRNA CTD PMID:16505366 , PMID:22498432 all-trans-retinoic acid multiple interactions ISO RGD:1322513 6480464 [Chir 99021 co-treated with BMP4 protein co-treated with FGF10 protein co-treated with FGF7 protein co-treated with Tretinoin] results in increased expression of SOX9 mRNA CTD PMID:35267148 all-trans-retinoic acid increases expression ISO RGD:1322513 6480464 Tretinoin results in increased expression of SOX9 mRNA CTD PMID:16480812 , PMID:23830798 all-trans-retinoic acid decreases expression EXP 6480464 Tretinoin results in decreased expression of SOX9 mRNA, Tretinoin results in decreased expression of SOX9 protein CTD PMID:23810783 all-trans-retinol multiple interactions ISO RGD:1322514 6480464 [RARA gene mutant form co-treated with Vitamin A] results in decreased expression of SOX9 mRNA, RARG gene mutant form inhibits the reaction [[RARA gene mutant form co-treated with Vitamin A] results in decreased expression of SOX9 mRNA] CTD PMID:16397886 allethrin multiple interactions EXP 6480464 [Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] results in increased expression of SOX9 mRNA, [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of SOX9 mRNA CTD PMID:33051911 , PMID:33396045 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of SOX9 mRNA CTD PMID:16483693 androgen antagonist multiple interactions EXP 6480464 [Pesticides co-treated with Phthalic Acids co-treated with Androgen Antagonists] results in increased expression of SOX9 mRNA CTD PMID:29945228 anthra[1,9-cd]pyrazol-6(2H)-one multiple interactions ISO RGD:1322513 6480464 pyrazolanthrone promotes the reaction [resveratrol results in increased expression of SOX9] CTD PMID:24841706 arachidonic acid decreases expression ISO RGD:1322513 6480464 Arachidonic Acid results in decreased expression of SOX9 mRNA CTD PMID:16704987 arsane decreases response to substance ISO RGD:1322513 6480464 SOX9 mRNA results in decreased susceptibility to Arsenic CTD PMID:17976673 arsane multiple interactions ISO RGD:1322513 6480464 [Arsenic co-treated with Estradiol] results in decreased expression of SOX9 mRNA CTD PMID:33047385 arsenic atom decreases response to substance ISO RGD:1322513 6480464 SOX9 mRNA results in decreased susceptibility to Arsenic CTD PMID:17976673 arsenic atom multiple interactions ISO RGD:1322513 6480464 [Arsenic co-treated with Estradiol] results in decreased expression of SOX9 mRNA CTD PMID:33047385 arsenite(3-) increases methylation ISO RGD:1322513 6480464 arsenite results in increased methylation of SOX9 promoter CTD PMID:23974009 atrazine increases expression ISO RGD:1322513 6480464 Atrazine results in increased expression of SOX9 mRNA CTD PMID:22378314 avobenzone increases expression ISO RGD:1322513 6480464 avobenzone results in increased expression of SOX9 mRNA CTD PMID:31016361 azoxystrobin decreases expression ISO RGD:1322513 6480464 azoxystrobin results in decreased expression of SOX9 mRNA CTD PMID:33512557 benzo[a]pyrene decreases expression ISO RGD:1322514 6480464 Benzo(a)pyrene results in decreased expression of SOX9 mRNA CTD PMID:15034205 more ... benzo[a]pyrene affects methylation ISO RGD:1322513 6480464 Benzo(a)pyrene affects the methylation of SOX9 promoter CTD PMID:27901495 benzo[a]pyrene increases expression ISO RGD:1322513 6480464 Benzo(a)pyrene results in increased expression of SOX9 mRNA CTD PMID:22316170 Benzo[ghi]perylene multiple interactions ISO RGD:1322513 6480464 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [1 more ... CTD PMID:35182551 Benzo[ghi]perylene increases expression ISO RGD:1322513 6480464 1, 12-benzoperylene results in increased expression of SOX9 mRNA CTD PMID:35182551 berberine decreases expression ISO RGD:1322513 6480464 Berberine results in decreased expression of SOX9 mRNA CTD PMID:26478571 bis(2-ethylhexyl) phthalate decreases expression EXP 6480464 Diethylhexyl Phthalate results in decreased expression of SOX9 mRNA CTD PMID:26472102 bis(2-ethylhexyl) phthalate decreases expression ISO RGD:1322514 6480464 Diethylhexyl Phthalate results in decreased expression of SOX9 mRNA, Diethylhexyl Phthalate results in decreased expression of SOX9 protein CTD PMID:26219507 , PMID:27060630 bisphenol A decreases expression ISO RGD:1322514 6480464 bisphenol A results in decreased expression of SOX9 mRNA CTD PMID:22732146 bisphenol A increases expression ISO RGD:1322514 6480464 bisphenol A results in increased expression of SOX9 mRNA CTD PMID:32156529 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of SOX9 mRNA CTD PMID:34947998 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of SOX9 mRNA, bisphenol A results in decreased expression of SOX9 protein CTD PMID:34973380 bisphenol A increases expression ISO RGD:1322513 6480464 bisphenol A results in increased expression of SOX9 mRNA CTD PMID:29718440 bisphenol A affects expression ISO RGD:1322513 6480464 bisphenol A affects the expression of SOX9 mRNA CTD PMID:30903817 bisphenol A affects methylation ISO RGD:1322514 6480464 bisphenol A affects the methylation of SOX9 promoter CTD PMID:27334623 Bisphenol B increases expression EXP 6480464 bisphenol B results in increased expression of SOX9 mRNA, bisphenol B results in increased expression of SOX9 protein CTD PMID:33940105 bisphenol F increases expression EXP 6480464 bisphenol F results in increased expression of SOX9 mRNA, bisphenol F results in increased expression of SOX9 protein CTD PMID:35803362 Brusatol multiple interactions ISO RGD:1322513 6480464 brusatol inhibits the reaction [KEAP1 gene mutant form results in increased expression of SOX9 protein] CTD PMID:32682831 Brusatol decreases expression ISO RGD:1322513 6480464 brusatol results in decreased expression of SOX9 mRNA CTD PMID:32682831 buta-1,3-diene decreases expression ISO RGD:1322514 6480464 1, 3-butadiene results in decreased expression of SOX9 mRNA CTD PMID:29038090 Butylbenzyl phthalate decreases expression EXP 6480464 butylbenzyl phthalate results in decreased expression of SOX9 mRNA CTD PMID:26472102 Butylbenzyl phthalate increases expression EXP 6480464 butylbenzyl phthalate results in increased expression of SOX9 mRNA, butylbenzyl phthalate results in increased expression of SOX9 protein CTD PMID:31319113 cadmium atom multiple interactions ISO RGD:1322513 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of SOX9 mRNA CTD PMID:35301059 cadmium dichloride multiple interactions ISO RGD:1322513 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of SOX9 mRNA CTD PMID:35301059 caffeine decreases expression EXP 6480464 Caffeine results in decreased expression of SOX9 mRNA, Caffeine results in decreased expression of SOX9 protein CTD PMID:31874197 , PMID:32663519 caffeine increases phosphorylation ISO RGD:1322513 6480464 Caffeine results in increased phosphorylation of SOX9 protein CTD PMID:35688186 calcitriol decreases expression ISO RGD:1322513 6480464 Calcitriol results in decreased expression of SOX9 mRNA CTD PMID:16002434 calcitriol increases expression ISO RGD:1322513 6480464 Calcitriol results in increased expression of SOX9 mRNA CTD PMID:21592394 calcitriol multiple interactions ISO RGD:1322513 6480464 [Testosterone co-treated with Calcitriol] results in increased expression of SOX9 mRNA CTD PMID:21592394 cannabidiol increases expression ISO RGD:1322513 6480464 Cannabidiol results in increased expression of SOX9 mRNA CTD PMID:27918106 carbon nanotube increases expression ISO RGD:1322514 6480464 Nanotubes, Carbon results in increased expression of SOX9 mRNA CTD PMID:25554681 more ... carmustine affects response to substance ISO RGD:1322513 6480464 SOX9 mRNA affects the susceptibility to Carmustine CTD PMID:16365179 CGP 52608 multiple interactions ISO RGD:1322513 6480464 CGP 52608 promotes the reaction [RORA protein binds to SOX9 gene] CTD PMID:28238834 CHIR 99021 decreases expression ISO RGD:1322514 6480464 Chir 99021 results in decreased expression of SOX9 mRNA CTD PMID:32220932 CHIR 99021 multiple interactions ISO RGD:1322513 6480464 [Chir 99021 co-treated with BMP4 protein co-treated with FGF10 protein co-treated with FGF7 protein co-treated with Tretinoin] results in increased expression of SOX9 mRNA CTD PMID:35267148 chlordecone decreases expression ISO RGD:1322514 6480464 Chlordecone results in decreased expression of SOX9 mRNA CTD PMID:33711761 chlorpyrifos increases methylation EXP 6480464 Chlorpyrifos results in increased methylation of SOX9 gene CTD PMID:32905263 choline multiple interactions ISO RGD:1322514 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of and results in increased expression of SOX9 more ... CTD PMID:20938992 chromium(6+) affects expression ISO RGD:1322514 6480464 chromium hexavalent ion affects the expression of SOX9 mRNA CTD PMID:28472532 ciguatoxin CTX1B affects expression ISO RGD:1322514 6480464 Ciguatoxins affects the expression of SOX9 mRNA CTD PMID:18353800 cisplatin decreases expression ISO RGD:1322513 6480464 Cisplatin results in decreased expression of SOX9 mRNA CTD PMID:27392435 cisplatin multiple interactions ISO RGD:1322513 6480464 [Cisplatin co-treated with jinfukang] results in decreased expression of SOX9 mRNA CTD PMID:27392435 clobetasol decreases expression ISO RGD:1322514 6480464 Clobetasol results in decreased expression of SOX9 mRNA CTD PMID:27462272 copper atom multiple interactions ISO RGD:1322513 6480464 [NSC 689534 binds to Copper] which results in decreased expression of SOX9 mRNA CTD PMID:20971185 copper(0) multiple interactions ISO RGD:1322513 6480464 [NSC 689534 binds to Copper] which results in decreased expression of SOX9 mRNA CTD PMID:20971185 copper(II) sulfate decreases expression ISO RGD:1322513 6480464 Copper Sulfate results in decreased expression of SOX9 mRNA CTD PMID:19549813 corticosterone decreases expression EXP 6480464 Corticosterone results in decreased expression of SOX9 mRNA, Corticosterone results in decreased expression of SOX9 protein CTD PMID:29660438 , PMID:32663519 coumestrol multiple interactions ISO RGD:1322513 6480464 [Coumestrol co-treated with 2, 3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of SOX9 mRNA CTD PMID:19167446 coumestrol decreases expression ISO RGD:1322513 6480464 Coumestrol results in decreased expression of SOX9 mRNA CTD PMID:19167446 crocidolite asbestos increases expression ISO RGD:1322513 6480464 Asbestos, Crocidolite results in increased expression of SOX9 mRNA CTD PMID:25351596 crotonaldehyde decreases expression ISO RGD:1322513 6480464 2-butenal results in decreased expression of SOX9 mRNA CTD PMID:20471460 Cuprizon increases expression EXP 6480464 Cuprizone results in increased expression of SOX9 mRNA CTD PMID:26577399 , PMID:27523638 curcumin multiple interactions ISO RGD:1322513 6480464 [Curcumin co-treated with resveratrol] results in increased expression of SOX9 protein CTD PMID:19889203 curcumin increases expression ISO RGD:1322513 6480464 Curcumin results in increased expression of SOX9 protein CTD PMID:19889203 cyclosporin A decreases expression ISO RGD:1322513 6480464 Cyclosporine results in decreased expression of SOX9 mRNA CTD PMID:19159671 , PMID:25562108 cyhalothrin multiple interactions EXP 6480464 [Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] results in increased expression of SOX9 mRNA, [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of SOX9 mRNA CTD PMID:33051911 , PMID:33396045 cypermethrin multiple interactions EXP 6480464 [Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] results in increased expression of SOX9 mRNA, [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of SOX9 mRNA CTD PMID:33051911 , PMID:33396045 decabromodiphenyl ether increases expression EXP 6480464 decabromobiphenyl ether results in increased expression of SOX9 mRNA CTD PMID:23914054 dexamethasone increases expression ISO RGD:1322513 6480464 Dexamethasone results in increased expression of SOX9 mRNA CTD PMID:17690025 dexamethasone decreases expression ISO RGD:1322513 6480464 Dexamethasone results in decreased expression of SOX9 mRNA CTD PMID:27608943 dexamethasone decreases expression ISO RGD:1322514 6480464 Dexamethasone results in decreased expression of SOX9 mRNA CTD PMID:22733784 , PMID:29329878 dexamethasone multiple interactions ISO RGD:1322513 6480464 [Ascorbic Acid co-treated with beta-glycerophosphoric acid co-treated with Dexamethasone] results in decreased expression of SOX9 mRNA more ... CTD PMID:17502159 more ... dextran sulfate multiple interactions ISO RGD:1322514 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of SOX9 mRNA CTD PMID:29950665 dibenz[a,h]anthracene decreases expression ISO RGD:1322514 6480464 1 more ... CTD PMID:26377693 dibutyl phthalate increases expression ISO RGD:1322514 6480464 Dibutyl Phthalate results in increased expression of SOX9 mRNA CTD PMID:17361019 , PMID:21266533 dibutyl phthalate decreases expression EXP 6480464 Dibutyl Phthalate results in decreased expression of SOX9 mRNA CTD PMID:26472102 , PMID:32525071 dibutyl phthalate multiple interactions EXP 6480464 taxifolin inhibits the reaction [Dibutyl Phthalate results in decreased expression of SOX9 mRNA] CTD PMID:32525071 dicrotophos increases expression ISO RGD:1322513 6480464 dicrotophos results in increased expression of SOX9 mRNA CTD PMID:28302478 diethyl maleate increases expression EXP 6480464 diethyl maleate results in increased expression of SOX9 mRNA CTD PMID:21161181 diheptyl phthalate decreases expression EXP 6480464 diheptyl phthalate results in decreased expression of SOX9 mRNA CTD PMID:22112501 diisobutyl phthalate increases expression EXP 6480464 diisobutyl phthalate results in increased expression of SOX9 mRNA CTD PMID:22112501 Diisodecyl phthalate decreases expression EXP 6480464 diisodecyl phthalate results in decreased expression of SOX9 mRNA, diisodecyl phthalate results in decreased expression of SOX9 protein CTD PMID:32387388 dioxygen increases expression ISO RGD:1322513 6480464 Oxygen deficiency results in increased expression of SOX9 protein CTD PMID:23406266 dioxygen multiple interactions ISO RGD:1322514 6480464 [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of SOX9 mRNA CTD PMID:30529165 dioxygen multiple interactions ISO RGD:1322513 6480464 cobaltiprotoporphyrin inhibits the reaction [IL1B protein inhibits the reaction [Oxygen deficiency results in increased expression of SOX9 protein]] more ... CTD PMID:23406266 dipentyl phthalate decreases expression EXP 6480464 di-n-pentyl phthalate results in decreased expression of SOX9 mRNA CTD PMID:26472102 disodium selenite multiple interactions ISO RGD:1322514 6480464 [Folic Acid co-treated with INS protein co-treated with TF protein co-treated with Sodium Selenite] results in increased expression of SOX9 mRNA CTD PMID:32324263 diuron increases expression EXP 6480464 Diuron results in increased expression of SOX9 mRNA CTD PMID:25152437 diuron decreases expression EXP 6480464 Diuron results in decreased expression of SOX9 mRNA CTD PMID:21551480 dorsomorphin multiple interactions ISO RGD:1322513 6480464 [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 doxorubicin increases expression ISO RGD:1322514 6480464 Doxorubicin results in increased expression of SOX9 mRNA CTD PMID:32579217 doxorubicin increases expression ISO RGD:1322513 6480464 Doxorubicin results in increased expression of SOX9 mRNA CTD PMID:30031762 doxorubicin decreases expression ISO RGD:1322513 6480464 Doxorubicin results in decreased expression of SOX9 mRNA CTD PMID:29803840 elemental selenium multiple interactions ISO RGD:1322513 6480464 [Selenium co-treated with Vitamin E] results in decreased expression of SOX9 mRNA CTD PMID:19244175 elemental selenium decreases expression ISO RGD:1322513 6480464 Selenium results in decreased expression of SOX9 mRNA CTD PMID:19244175 endosulfan decreases expression ISO RGD:1322513 6480464 Endosulfan results in decreased expression of SOX9 mRNA CTD PMID:26615145 Enterolactone multiple interactions ISO RGD:1322513 6480464 [Coumestrol co-treated with 2, 3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of SOX9 mRNA CTD PMID:19167446 enzalutamide affects expression ISO RGD:1322513 6480464 enzalutamide affects the expression of SOX9 mRNA CTD PMID:30940724 erlotinib hydrochloride multiple interactions ISO RGD:1322513 6480464 Erlotinib Hydrochloride inhibits the reaction [EGFR protein mutant form results in increased expression of SOX9 mRNA], Erlotinib Hydrochloride inhibits the reaction [EGFR protein mutant form results in increased expression of SOX9 protein] CTD PMID:26455392 erlotinib hydrochloride decreases expression ISO RGD:1322513 6480464 Erlotinib Hydrochloride results in decreased expression of SOX9 protein CTD PMID:26455392 ethanol decreases expression ISO RGD:1322514 6480464 Ethanol results in decreased expression of SOX9 protein CTD PMID:28285099 ethanol affects splicing ISO RGD:1322514 6480464 Ethanol affects the splicing of SOX9 mRNA CTD PMID:30319688 ethanol decreases expression EXP 6480464 Ethanol results in decreased expression of SOX9 mRNA CTD PMID:29617878 ethanol multiple interactions ISO RGD:1322514 6480464 [Ethanol co-treated with Carbon Tetrachloride] results in decreased methylation of SOX9 promoter more ... CTD PMID:28285099 Ethylenethiourea increases expression EXP 6480464 Ethylenethiourea results in increased expression of SOX9 protein CTD PMID:35930101 fenvalerate multiple interactions EXP 6480464 [Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] results in increased expression of SOX9 mRNA, [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of SOX9 mRNA CTD PMID:33051911 , PMID:33396045 folic acid multiple interactions ISO RGD:1322514 6480464 [Folic Acid co-treated with INS protein co-treated with TF protein co-treated with Sodium Selenite] results in increased expression of SOX9 mRNA more ... CTD PMID:20938992 , PMID:32324263 formaldehyde increases expression ISO RGD:1322513 6480464 Formaldehyde results in increased expression of SOX9 mRNA CTD PMID:23416264 formaldehyde decreases expression ISO RGD:1322513 6480464 Formaldehyde results in decreased expression of SOX9 mRNA CTD PMID:28937961 gallic acid decreases expression EXP 6480464 Gallic Acid results in decreased expression of SOX9 mRNA CTD PMID:26107568 genistein decreases expression ISO RGD:1322514 6480464 Genistein results in decreased expression of SOX9 mRNA CTD PMID:32186404 geraniol decreases expression ISO RGD:1322513 6480464 geraniol results in decreased expression of SOX9 mRNA CTD PMID:27683099 glycerol 2-phosphate multiple interactions ISO RGD:1322513 6480464 [Ascorbic Acid co-treated with beta-glycerophosphoric acid co-treated with Dexamethasone] results in decreased expression of SOX9 mRNA CTD PMID:26424790 glycidol decreases expression EXP 6480464 glycidol results in decreased expression of SOX9 mRNA CTD PMID:24915197 hyaluronic acid multiple interactions ISO RGD:1322514 6480464 [Hyaluronic Acid co-treated with resveratrol] results in increased expression of SOX9 mRNA CTD PMID:23595953 hydralazine multiple interactions ISO RGD:1322513 6480464 [Hydralazine co-treated with Valproic Acid] results in increased expression of SOX9 mRNA CTD PMID:17183730 hydrogen peroxide increases expression ISO RGD:1322514 6480464 Hydrogen Peroxide results in increased expression of SOX9 mRNA CTD PMID:32579217 indole-3-methanol affects expression EXP 6480464 indole-3-carbinol affects the expression of SOX9 mRNA CTD PMID:21396975 inulin multiple interactions ISO RGD:1322514 6480464 [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of SOX9 mRNA CTD PMID:36331819 iohexol increases expression ISO RGD:1322513 6480464 Iohexol results in increased expression of SOX9 mRNA CTD PMID:29705293 ionomycin multiple interactions ISO RGD:1322514 6480464 Ionomycin affects the reaction [CALR protein affects the expression of SOX9 mRNA] CTD PMID:32220932 iopamidol increases expression ISO RGD:1322513 6480464 Iopamidol results in increased expression of SOX9 mRNA CTD PMID:29705293 iron atom increases expression EXP 6480464 Iron deficiency results in increased expression of SOX9 mRNA CTD PMID:16629162 iron(0) increases expression EXP 6480464 Iron deficiency results in increased expression of SOX9 mRNA CTD PMID:16629162 kaempferol increases expression ISO RGD:1322514 6480464 kaempferol results in increased expression of SOX9 mRNA CTD PMID:23989061 L-ascorbic acid multiple interactions ISO RGD:1322513 6480464 [Ascorbic Acid co-treated with beta-glycerophosphoric acid co-treated with Dexamethasone] results in decreased expression of SOX9 mRNA more ... CTD PMID:26424790 , PMID:26526931 L-methionine multiple interactions ISO RGD:1322514 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of and results in increased expression of SOX9 more ... CTD PMID:20938992 lead diacetate multiple interactions ISO RGD:1322514 6480464 BMP2 promotes the reaction [lead acetate results in increased expression of SOX9 mRNA], lead acetate promotes the reaction [BMP2 results in increased expression of SOX9 mRNA] CTD PMID:17805416 lead diacetate increases expression ISO RGD:1322514 6480464 lead acetate results in increased expression of SOX9 mRNA CTD PMID:17805416 leflunomide increases expression ISO RGD:1322513 6480464 leflunomide results in increased expression of SOX9 mRNA CTD PMID:28988120 Licochalcone B increases expression ISO RGD:1322513 6480464 licochalcone B results in increased expression of SOX9 mRNA CTD PMID:33647349 methapyrilene increases expression ISO RGD:1322513 6480464 Methapyrilene results in increased expression of SOX9 protein CTD PMID:28935588 methylisothiazolinone increases expression ISO RGD:1322513 6480464 2-methyl-4-isothiazolin-3-one results in increased expression of SOX9 mRNA CTD PMID:31629900 mifepristone increases expression ISO RGD:1322513 6480464 Mifepristone results in increased expression of SOX9 mRNA CTD PMID:17584828 Mofezolac (TN) multiple interactions ISO RGD:1322514 6480464 [mofezolac results in decreased activity of PTGS1 protein] which results in decreased expression of SOX9 mRNA, [mofezolac results in decreased activity of PTGS1 protein] which results in decreased expression of SOX9 protein CTD PMID:27050768 Monobutylphthalate decreases expression ISO RGD:1322514 6480464 monobutyl phthalate results in decreased expression of SOX9 mRNA CTD PMID:28496037 N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal multiple interactions ISO RGD:1322513 6480464 [benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in decreased degradation of SRY protein mutant form] which results in increased expression of SOX9 mRNA CTD PMID:27576690 nickel sulfate increases expression ISO RGD:1322513 6480464 nickel sulfate results in increased expression of SOX9 mRNA CTD PMID:18651567 nicotinamide decreases expression ISO RGD:1322513 6480464 Niacinamide results in decreased expression of SOX9 protein CTD PMID:24962570 nicotinamide multiple interactions ISO RGD:1322513 6480464 4(2'-aminoethyl)amino-1 more ... CTD PMID:24962570 nicotine decreases expression EXP 6480464 Nicotine results in decreased expression of SOX9 mRNA, Nicotine results in decreased expression of SOX9 protein CTD PMID:29660438 , PMID:31299270 oxybenzone multiple interactions EXP 6480464 4-(2-phenyl-5 more ... CTD PMID:30599193 oxybenzone increases expression EXP 6480464 oxybenzone results in increased expression of SOX9 mRNA CTD PMID:30599193 ozone multiple interactions ISO RGD:1322514 6480464 [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of SOX9 mRNA CTD PMID:34911549 panobinostat increases expression ISO RGD:1322513 6480464 panobinostat results in increased expression of SOX9 mRNA CTD PMID:26272509 panobinostat multiple interactions ISO RGD:1322513 6480464 [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SOX9 mRNA CTD PMID:27188386 paracetamol affects expression ISO RGD:1322514 6480464 Acetaminophen affects the expression of SOX9 mRNA CTD PMID:17562736 paraquat decreases expression ISO RGD:1322514 6480464 Paraquat results in decreased expression of SOX9 mRNA CTD PMID:26108578 paraquat affects expression EXP 6480464 Paraquat affects the expression of SOX9 mRNA, Paraquat affects the expression of SOX9 protein CTD PMID:31128353 PD 0325901 decreases expression ISO RGD:1322513 6480464 mirdametinib results in decreased expression of SOX9 mRNA CTD PMID:25119042 perfluorododecanoic acid decreases expression EXP 6480464 perfluorododecanoic acid results in decreased expression of SOX9 mRNA, perfluorododecanoic acid results in decreased expression of SOX9 protein CTD PMID:33774092 perfluorononanoic acid increases expression ISO RGD:1322513 6480464 perfluoro-n-nonanoic acid results in increased expression of SOX9 mRNA CTD PMID:32588087 perfluorooctane-1-sulfonic acid increases expression ISO RGD:1322513 6480464 perfluorooctane sulfonic acid results in increased expression of SOX9 mRNA CTD PMID:32588087 perfluorooctane-1-sulfonic acid multiple interactions ISO RGD:1322514 6480464 [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of SOX9 mRNA CTD PMID:36331819 PhIP increases expression EXP 6480464 2-amino-1-methyl-6-phenylimidazo(4, 5-b)pyridine results in increased expression of SOX9 mRNA CTD PMID:15215175 pirinixic acid multiple interactions ISO RGD:1322514 6480464 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of SOX9 mRNA CTD PMID:19710929 pirinixic acid increases expression ISO RGD:1322514 6480464 pirinixic acid results in increased expression of SOX9 mRNA CTD PMID:18445702 , PMID:23811191 prednisolone decreases expression ISO RGD:1322513 6480464 Prednisolone results in decreased expression of SOX9 mRNA CTD PMID:17379860 progesterone multiple interactions ISO RGD:1322513 6480464 [Progesterone co-treated with Estradiol] results in decreased expression of SOX9 mRNA CTD PMID:17404688 progesterone decreases expression ISO RGD:1322514 6480464 Progesterone results in decreased expression of SOX9 mRNA CTD PMID:22238285 progesterone increases expression ISO RGD:1322513 6480464 Progesterone results in increased expression of SOX9 mRNA CTD PMID:21795739 progesterone decreases expression ISO RGD:1322513 6480464 Progesterone results in decreased expression of SOX9 mRNA CTD PMID:17404688 prostaglandin E2 increases expression ISO RGD:1322514 6480464 Dinoprostone results in increased expression of SOX9 mRNA, Dinoprostone results in increased expression of SOX9 protein CTD PMID:27050768 prostaglandin F2alpha increases expression ISO RGD:1322514 6480464 Dinoprost results in increased expression of SOX9 mRNA, Dinoprost results in increased expression of SOX9 protein CTD PMID:27050768 rac-lactic acid increases expression ISO RGD:1322513 6480464 Lactic Acid results in increased expression of SOX9 mRNA CTD PMID:30851411 resmethrin increases expression ISO RGD:1322514 6480464 resmethrin results in increased expression of SOX9 mRNA CTD PMID:31593228 resveratrol multiple interactions ISO RGD:1322513 6480464 [Curcumin co-treated with Resveratrol] results in increased expression of SOX9 protein more ... CTD PMID:19889203 more ... resveratrol multiple interactions ISO RGD:1322514 6480464 [Hyaluronic Acid co-treated with resveratrol] results in increased expression of SOX9 mRNA CTD PMID:23595953 resveratrol increases expression ISO RGD:1322513 6480464 resveratrol results in increased expression of SOX9, resveratrol results in increased expression of SOX9 protein CTD PMID:19889203 more ... rotenone decreases expression ISO RGD:1322513 6480464 Rotenone results in decreased expression of SOX9 mRNA CTD PMID:33512557 rotenone increases expression ISO RGD:1322514 6480464 Rotenone results in increased expression of SOX9 mRNA CTD PMID:32937126 SB 203580 multiple interactions ISO RGD:1322513 6480464 SB 203580 inhibits the reaction [resveratrol results in increased expression of SOX9] CTD PMID:24841706 SB 431542 multiple interactions ISO RGD:1322513 6480464 [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 selenium atom multiple interactions ISO RGD:1322513 6480464 [Selenium co-treated with Vitamin E] results in decreased expression of SOX9 mRNA CTD PMID:19244175 selenium atom decreases expression ISO RGD:1322513 6480464 Selenium results in decreased expression of SOX9 mRNA CTD PMID:19244175 silicon dioxide increases expression ISO RGD:1322513 6480464 Silicon Dioxide results in increased expression of SOX9 mRNA CTD PMID:22300531 , PMID:25351596 silicon dioxide decreases methylation ISO RGD:1322513 6480464 Silicon Dioxide results in decreased methylation of SOX9 promoter CTD PMID:34973136 silver atom decreases expression ISO RGD:1322514 6480464 Silver results in decreased expression of SOX9 mRNA CTD PMID:27131904 silver atom decreases expression ISO RGD:1322513 6480464 Silver results in decreased expression of SOX9 mRNA CTD PMID:26014281 silver(0) decreases expression ISO RGD:1322514 6480464 Silver results in decreased expression of SOX9 mRNA CTD PMID:27131904 silver(0) decreases expression ISO RGD:1322513 6480464 Silver results in decreased expression of SOX9 mRNA CTD PMID:26014281 sirolimus decreases expression ISO RGD:1322514 6480464 Sirolimus results in decreased expression of SOX9 protein CTD PMID:34536393 sodium arsenite decreases expression ISO RGD:1322514 6480464 sodium arsenite results in decreased expression of SOX9 mRNA CTD PMID:28206643 sodium arsenite increases expression ISO RGD:1322513 6480464 sodium arsenite results in increased expression of SOX9 mRNA, sodium arsenite results in increased expression of SOX9 protein CTD PMID:32682831 sodium arsenite increases response to substance ISO RGD:1322513 6480464 SOX9 results in increased susceptibility to sodium arsenite CTD PMID:32682831 sodium fluoride multiple interactions ISO RGD:1322514 6480464 4 more ... CTD PMID:34536393 sodium fluoride decreases expression ISO RGD:1322514 6480464 Sodium Fluoride results in decreased expression of SOX9 mRNA, Sodium Fluoride results in decreased expression of SOX9 protein CTD PMID:34536393 Soman increases expression EXP 6480464 Soman results in increased expression of SOX9 mRNA CTD PMID:19281266 sulfamethoxazole decreases expression EXP 6480464 Sulfamethoxazole results in decreased expression of SOX9 mRNA CTD PMID:26107568 sulforaphane increases expression ISO RGD:1322513 6480464 sulforaphane results in increased expression of SOX9 mRNA, sulforaphane results in increased expression of SOX9 protein CTD PMID:32682831 sunitinib decreases expression ISO RGD:1322513 6480464 Sunitinib results in decreased expression of SOX9 mRNA CTD PMID:31533062 tacrolimus hydrate increases expression ISO RGD:1322514 6480464 Tacrolimus results in increased expression of SOX9 mRNA CTD PMID:29362864 tamoxifen affects expression ISO RGD:1322513 6480464 Tamoxifen affects the expression of SOX9 mRNA CTD PMID:14699072 tamoxifen increases expression ISO RGD:1322514 6480464 Tamoxifen results in increased expression of SOX9 mRNA, Tamoxifen results in increased expression of SOX9 protein CTD PMID:24769059 temozolomide affects response to substance ISO RGD:1322513 6480464 SOX9 mRNA affects the susceptibility to temozolomide CTD PMID:16365179 temozolomide increases expression ISO RGD:1322513 6480464 Temozolomide results in increased expression of SOX9 mRNA CTD PMID:31758290 tert-butyl hydroperoxide increases expression ISO RGD:1322513 6480464 tert-Butylhydroperoxide results in increased expression of SOX9 mRNA CTD PMID:15336504 testosterone multiple interactions ISO RGD:1322513 6480464 [Testosterone co-treated with Calcitriol] results in increased expression of SOX9 mRNA CTD PMID:21592394 testosterone increases expression ISO RGD:1322513 6480464 Testosterone results in increased expression of SOX9 mRNA CTD PMID:21592394 tetrachloromethane multiple interactions ISO RGD:1322514 6480464 [Carbon Tetrachloride results in increased expression of SOX9 protein] promotes the reaction [SOX9 protein binds to H19 promoter] more ... CTD PMID:28285099 more ... tetrachloromethane increases expression ISO RGD:1322514 6480464 Carbon Tetrachloride results in increased expression of SOX9 mRNA, Carbon Tetrachloride results in increased expression of SOX9 protein CTD PMID:31919559 more ... tetrachloromethane increases response to substance ISO RGD:1322514 6480464 SOX9 results in increased susceptibility to Carbon Tetrachloride CTD PMID:32579217 thimerosal increases expression ISO RGD:1322514 6480464 Thimerosal results in increased expression of SOX9 mRNA CTD PMID:24675092 thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of SOX9 mRNA CTD PMID:34492290 titanium dioxide decreases expression ISO RGD:1322514 6480464 titanium dioxide results in decreased expression of SOX9 mRNA CTD PMID:23557971 titanium dioxide multiple interactions ISO RGD:1322514 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of SOX9 mRNA CTD PMID:29950665 titanium dioxide increases expression ISO RGD:1322514 6480464 titanium dioxide results in increased expression of SOX9 mRNA CTD PMID:29264374 torin 1 multiple interactions ISO RGD:1322513 6480464 1-(4-(4-propionylpiperazin-1-yl)-3-(trifluoromethyl)phenyl)-9-(quinolin-3-yl)benzo(h)(1 more ... CTD PMID:26455392 triacsin C decreases expression ISO RGD:1322513 6480464 triacsin C results in decreased expression of SOX9 mRNA CTD PMID:16704987 tributylstannane multiple interactions ISO RGD:1322514 6480464 [tributyltin co-treated with Tetrachlorodibenzodioxin] results in decreased expression of SOX9 mRNA CTD PMID:22749964 tributylstannane decreases expression ISO RGD:1322514 6480464 tributyltin results in decreased expression of SOX9 mRNA CTD PMID:24513447 trichostatin A increases expression ISO RGD:1322513 6480464 trichostatin A results in increased expression of SOX9 mRNA CTD PMID:24935251 , PMID:26272509 trichostatin A multiple interactions ISO RGD:1322513 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SOX9 mRNA CTD PMID:27188386 triclosan decreases expression ISO RGD:1322513 6480464 Triclosan results in decreased expression of SOX9 mRNA CTD PMID:30510588 triphenyl phosphate affects expression ISO RGD:1322514 6480464 triphenyl phosphate affects the expression of SOX9 mRNA CTD PMID:30561715 troglitazone increases expression ISO RGD:1322513 6480464 troglitazone results in increased expression of SOX9 mRNA CTD PMID:19140230 urethane increases expression ISO RGD:1322513 6480464 Urethane results in increased expression of SOX9 mRNA CTD PMID:28818685 valproic acid multiple interactions ISO RGD:1322513 6480464 [Hydralazine co-treated with Valproic Acid] results in increased expression of SOX9 mRNA CTD PMID:17183730 valproic acid increases methylation ISO RGD:1322513 6480464 Valproic Acid results in increased methylation of SOX9 gene CTD PMID:29154799 valproic acid decreases expression ISO RGD:1322514 6480464 Valproic Acid results in decreased expression of SOX9 mRNA CTD PMID:23042728 , PMID:31445079 valproic acid affects expression ISO RGD:1322513 6480464 Valproic Acid affects the expression of SOX9 mRNA CTD PMID:25979313 valproic acid increases expression ISO RGD:1322513 6480464 Valproic Acid results in increased expression of SOX9 mRNA CTD PMID:24383497 more ... vitamin E multiple interactions ISO RGD:1322513 6480464 [Selenium co-treated with Vitamin E] results in decreased expression of SOX9 mRNA CTD PMID:19244175 vitamin E decreases expression ISO RGD:1322513 6480464 Vitamin E results in decreased expression of SOX9 mRNA CTD PMID:19244175 vorinostat multiple interactions ISO RGD:1322513 6480464 [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 , PMID:34250664 vorinostat increases expression ISO RGD:1322513 6480464 vorinostat results in increased expression of SOX9 mRNA CTD PMID:26272509 XL147 multiple interactions ISO RGD:1322514 6480464 XL147 inhibits the reaction [N-nitroso-tris-chloroethylurea results in increased expression of SOX9 mRNA] CTD PMID:29891994 zearalenone decreases expression ISO RGD:1322514 6480464 Zearalenone results in decreased expression of SOX9 mRNA CTD PMID:24412631 zileuton increases expression ISO RGD:1322514 6480464 zileuton results in increased expression of SOX9 mRNA CTD PMID:19544365 ziram decreases expression EXP 6480464 Ziram results in decreased expression of SOX9 mRNA, Ziram results in decreased expression of SOX9 protein CTD PMID:29627606 zoledronic acid decreases expression ISO RGD:1322513 6480464 zoledronic acid results in decreased expression of SOX9 mRNA CTD PMID:24714768
